Navigation Links
Genzyme Provides Update on Myozyme(R) Manufacturing
Date:4/21/2008

Will Host Conference Call Today at 5:00 p.m.

CAMBRIDGE, Mass., April 21 /PRNewswire-FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA has informed the company of its opinion that Myozyme(R) (alglucosidase alfa) produced at the 160L bioreactor scale and Myozyme produced at the 2000L scale should be classified as two different products because of differences in the carbohydrate structures of the molecules. Currently, Genzyme has U.S. approval to sell Myozyme manufactured at the 160L scale, and the company has been seeking clearance from the FDA for Myozyme produced at the 2000L scale. Production at this larger scale has already been approved in more than 40 countries.

Based on the global clinical experience of nearly 900 patients of all ages currently receiving Myozyme produced at the larger scale, including patients who participated in the Late-Onset Treatment Study (LOTS), Genzyme believes that Myozyme produced at both the 160L and 2000L scales is clinically effective and safe. Myozyme is the only treatment for Pompe disease -- a severe, progressively debilitating and life-threatening inherited disorder affecting a very small number of people throughout the world.

The FDA will require Genzyme to submit a separate biologics license application (BLA) to gain approval for Myozyme produced at the 2000L scale. The agency proposed that Genzyme initiate a rolling BLA review process by submitting results from the LOTS study. Genzyme expects the FDA to give the BLA priority review and to act on the application by the end of this year. The LOTS study, which met its co-primary efficacy endpoints, was undertaken to evaluate the safety and efficacy of Myozyme in juvenile and adult patients w
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
2. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
3. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
4. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
7. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
8. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
9. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
10. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
11. Genzyme Launches Cholestagel(R) in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014   SunTrust Robinson Humphrey (STRH) ... to its equity research team in biotechnology and ... in equity research demonstrates our commitment to providing ... enhance their investment decision making," said Biff ... continue to make significant investments in differentiated content ...
(Date:8/28/2014)... USA (PRWEB) August 27, 2014 Scientists, ... month for SPIE Laser Damage 2014 symposium. ... materials for high-power lasers will run 14-17 September. The ... for optics and photonics . , The premier conference ... understanding laser damage to optical materials will engage researchers ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Supplementing ... offering a promotion for Eppendorf Safe Lock ... to purchase the highest quality tubes at an ... ideal for customers doing chemical, medical, pharmaceutical, and ... who are not regularly able to afford Eppendorf ...
(Date:8/27/2014)... BOSTON , Aug. 27, 2014 Rhythm, ... diseases and genetic deficiencies that result in metabolic disorders, ... on Form S-1 with the U.S. Securities and Exchange ... of shares of its common stock. The number of ... the offering have not yet been determined. ...
Breaking Biology Technology:SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2
... , , , , , ... mRNA expression , pattern of a cell is examined in ... exogenous influences such as viral infections or medical treatment. , ... to cDNA. If all isolated mRNAs of a cell ...
... , , , Guy Adami, Department ... Vincent Prezioso, Eppendorf Scientific, Inc., Westbury, NY, USA , ... , Transgenic mice ... into their genome. The most common method of introducing recombinant DNA , ...
... , , , George Halley and Vincent ... Boulder, CO, USA , Vincent Prezioso, Brinkmann Instruments, BioSytems Application Lab, ... , Abstract , ... and their ability to reduce nonspecific amplification. Typical Hot Start , ...
Cached Biology Technology:Normalizing cDNA libraries using the EppendorfThermomixer 2Normalizing cDNA libraries using the EppendorfThermomixer 3Normalizing cDNA libraries using the EppendorfThermomixer 4The use of TaqMaster PCR Enhancer 2The use of TaqMaster PCR Enhancer 3The use of TaqMaster PCR Enhancer 4The use of TaqMaster PCR Enhancer 5HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 2HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 3HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 4HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 5HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 6HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 7
(Date:8/29/2014)... such as the prolific bloomer Emiliania huxleyi , ... discovered. The finding contradicts the common view that ... on scarce supplies of thiamine in the ocean to ... about the ocean," says CIFAR Senior Fellow Alexandra ... paper with CIFAR fellows John Archibald (Dalhousie ...
(Date:8/29/2014)... them, twist them, fold them: modern materials that are ... whether as artificial skin or electronic paper. , Making ... challenge but a new way of working with copper ... game-changer. , Previous success in the field of ... of precious gold and silver nanowires. , By ...
(Date:8/28/2014)... Invasives is now available from the Lady Bird Johnson ... for identifying harmful non-native plant, insect and other invasive ... States cause about $137 billion in economic and other ... kill native plants and more. , "By having streamlined ... invasive species occur, we,re more likely to catch these ...
Breaking Biology News(10 mins):Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Copper shines as flexible conductor 2Mobile app makes ID of harmful plants, insects in Texas a snap 2
... Israeli Chairmanship of EUREKA, the largest pan-European network for ... from a report conducted by Kalman Gayer and the ... mark the completion of Israel,s Chairmanship year and EUREKA,s ... of EUREKA on companies participating in EUREKA programs. ...
... in German . Usher syndrome is ... and affects 1 in 6,000 of the population. It is ... heterogeneous. In the most severe cases, patients are born deaf ... in puberty, ultimately resulting in complete blindness. These patients experience ...
... most abundant parasites on Earth. Well known viruses, such as ... the tobacco mosaic virus infect plant hosts. More common, ... as bacteriophages, or phages. In part, this is due to ... cut off from their usual biological surroundings in a process ...
Cached Biology News:Is governmental investment in industrial R&D paying off? 2Is governmental investment in industrial R&D paying off? 3Treatment approach to human Usher syndrome: Small molecules ignore stop signals 2Treatment approach to human Usher syndrome: Small molecules ignore stop signals 3When viruses infect bacteria 2
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
... is produced by a patented microwave ... surface giving more consistent, even cell ... CellBIND enhances cell attachment and growth ... or serum-free medium. • Both enzymatic ...
... Bio-Plex suspension array system, 100-240 V, uses ... simultaneous quantitative analysis of up to 100 ... well. The suspension array is composed of ... of which may be conjugated with a ...
Biology Products: